Delivery Order SPE2DB22D2009-SPE2DB25FM1KP
Award Date 9/10/25
Potential Completion Date 9/11/25
Potential Value $1.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,119.24 to AmerisourceBergen Drug Corp for Belsomra 15 mg tablets (30-count supply) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award for pharmaceutical supply to support federal medical procurement needs. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Belsomra 10mg tablets (30-count) under a firm fixed-price contract valued at $1,072.12. This competitively awarded, non-set-aside delivery order is set to complete by September 3, 2025, with performance occurring at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,069.68 to AmerisourceBergen Drug Corp for 30 tablets of Belsomra 10 mg on July 30, 2025. This non-set-aside contract employs firm fixed pricing and is classified as a delivery order, with an ultimate completion date of July 31, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. The award represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Belsomra 10 mg tablets (30-count units) valued at $1,705.53 under a firm fixed price contract type. The award, issued on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a competitively awarded, non-set-aside contract. AmerisourceBergen's place of performance is located in Conshohocken, Pennsylvania, the company's corporate headquarters and a major hub for pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,101.78 to AmerisourceBergen Drug Corp for the supply of Belsomra 10 mg tablets (30-count units) on July 31, 2025, with an ultimate completion date of August 1, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation reflects a routine pharmaceutical supply transaction supporting federal medical procurement needs. The place of performance is listed as Conshohocken, Pennsylvania, which serves...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order contract award from the Defense Logistics Agency (DLA) on July 22, 2025, for the supply of Belsomra 20 mg tablets in a quantity of 30 units. This is a firm fixed price delivery order with a ceiling value of $1,181.89 and an ultimate completion date of July 23, 2025. The award was made through open competition with no set-aside designation. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,185.57 delivery order to AmerisourceBergen Drug Corp for 30 tablets of Belsomra 20 mg, a pharmaceutical product for treating insomnia. This competitively awarded, firm fixed-price contract was issued on September 11, 2025, with an ultimate completion date of September 12, 2025, and involves performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Belsomra 20 mg tablets (30-count packaging) valued at $1,305.88. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is set to be completed by September 4, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. Belsomra (suvorexant) is a prescription sleep...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,427.58 to AmerisourceBergen Drug Corp for Belsomra 10 mg tablets (30-count) on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price contract was awarded competitively with no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Belsomra is a prescription medication used for sleep disorders, reflecting the pharmaceutical...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Belsomra 10 mg tablets. The $1,483.02 contract has an ultimate completion date of March 27, 2024. AmerisourceBergen Drug Corp is the prime contractor and has not been designated a small business set-aside. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up...